AFC
HALO icon

Ares Financial Consulting’s Halozyme HALO Stock Holding History

Ares Financial Consulting’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Hold
154
– – 0.01% 533
2026
Q1 		$10.1K Hold
154
– – 0.01% 543
2025
Q4 		$10.4K Buy
+154
New +$10.4K 0.01% 356

Other funds holding HALO

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Ares Financial Consulting's HALO Position: Q2 2026 in Review

Ares Financial Consulting held its Halozyme (HALO) position steady in Q2 2026 at 154 shares worth $12.1K. The position accounts for 0.01% of the portfolio, ranked #533.

Ares Financial Consulting first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Ares Financial Consulting held 154 shares of Halozyme worth $12.1K as of Q2 2026.
  • Ares Financial Consulting left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #533 holding.
  • Ares Financial Consulting first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • 311 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.